Inhibrx
INBX

Inhibrx (INBX) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$1.85
EPS estimate
−$2.76
Revenue
$1.3M
Reported
Aug 13, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 13, 2025−$2.76−$1.85+32.97%$1.3MSEC
Q4 2024Mar 17, 2025−$2.89−$3.09−7.11%$100,000.00SEC

Quarterly revenue

Q4 2024
$100,000.00
Q2 2025
$1.3M

Frequently asked questions

  • When did Inhibrx (INBX) last report earnings?

    Inhibrx last reported on Aug 13, 2025, covering fiscal Q2 2025.

  • Did INBX beat earnings estimates?

    Yes. Inhibrx reported EPS of −$1.85 for Q2 2025 against a −$2.76 estimate — a 32.97% beat.

  • How much revenue did INBX report last quarter?

    Inhibrx reported $1.3M in revenue for Q2 2025.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.